PYTEST 14C-Urea Breath Test

Phase 3Small molecule

PYTEST 14C-Urea Breath Test is one of 14 small molecule programs targeting Helicobacter Pylori. It is currently in Phase 3.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Helicobacter PyloriActive, not recruiting

Helicobacter PyloriPhase 3

Active, not recruiting

Competition

Competitive Landscape

17 competitors in Helicobacter Pylori

#DrugCompanyPhaseTrials

Biaxin

AbbVie

Approved

13 2

Amoxil

GGlobal Antibiotics Research and Development Partnership

Approved

17 3

Nexium

DDexcel Pharma Technologies Ltd.

Approved

16 4

Potassium Citrate

MMission Pharmacal

Approved

11 5

Flagyl

DDePuy Orthopaedics

Approved

8 6

Vibramycin

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

2 7

Alinia

RRomark Laboratories L.C.

Phase 3

2 8

Keverprazan

NNanjing First Hospital, Nanjing Medical University

Phase 3

2 9

Proton Pump Inhibitor

AAVM Biotechnology Inc

Phase 3

1 10

PYTEST 14C-Urea Breath Test

UUniversity of Miami

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q4 2027

Post-ApprovalActive, not recruiting

Helicobacter Pylori

NCT07224048

Post-ApprovalActive, not recruiting

Helicobacter Pylori

NCT07224035

Clinical

Trials by Indication[1]

Helicobacter Pylori2 trials

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community-AIM 2

Active, not recruiting·UUniversity of Miami·Phase 4·NCT07224048·75 enrolled

Helicobacter Pylori Screening and Treatment in the At-risk South Florida Community- AIM 1

Active, not recruiting·UUniversity of Miami·Phase 4·NCT07224035·500 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for PYTEST 14C-Urea Breath Test. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — PYTEST 14C-Urea Breath Test compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for PYTEST 14C-Urea Breath Test. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — University of Miami company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: UUniversity of Miami

PYTEST 14C-Urea Breath Test

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q4 2027

Trials by Indication[1]

Helicobacter Pylori2 trials

References

Drug Info

Quick Facts

Related News